Partner & Employee Best Access
First time users must log in to Best Access via the Virtual Environment, not via this link.

Publication

November 9, 2013Published Article

Should ANVISA be Permitted to Reject Pharmaceutical Patent Applications in Brazil?

Expert Opinion on Therapeutic Patents

back to top